1,300 and counting. That’s how many executives placed by Borderless are contributing to the success of our clients. And while we are proud of these executives and the positions they have attained in their industries, we always ask ourselves what more can we do to boost the lives of the several thousands of people touched by our conversations each year?
We believe that answers will be found when you permit us to take the time to get to know each other, your business and personal aspirations. Diverse perspectives and experiences in our earlier lives as international executives in your sector will certainly ease the exchange, open doors and speed success.
Clients across the entire chemical value chain know they can rely on our executive search expertise and industry know-how.
From start-ups to established corporations, we assist clients across the life sciences sector to attract forward-looking leaders.
Makers of vegan snacks, high protein foods and the world’s favourite beer, look to us to find leaders in tune with consumer trends.
Tell us more about yourself, your career and your aspirations.
We truly think and act in a borderless way.
We care about your career and your business. No border can stop us from finding the perfect match or solution.
Eastman Chemical Co. (Kingsport, Tenn.) announced it has acquired Ai-Red Technology (Dalian) Co., Ltd., a manufacturer and supplier of paint protection and window film for auto and architectural markets in the Asia Pacific region.
The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens Soerensen, Professor and Clinical Advisor to MedTrace, are the originators of the method.
Schumacher will replace Alan Jope, who announced his decision to retire last September, less than a year after a failed attempt by Unilever to buy GlaxoSmithKline’s consumer healthcare business and just months after activist investor Nelson Peltz joined the company’s board.